This study investigated the influence of progestin priming and ovarian quiescence on response to exogenous gonadotropin stimulation in the cat. Because a subpopulation of cats routinely ovulated spontaneously, there also was the opportunity to examine the ovary's reaction to the added impact of endogenously secreted progestagen. Queens were given 1) equine chorionic gonadotropin (eCG) plus human chorionic gonadotropin (hCG) only (control; n ¼ 9 cats), 2) GnRH antagonist (antide) injections followed by eCG and hCG (n ¼ 9), and 3) a progestin implant (levonorgestrel) followed by eCG and hCG (n ¼ 9). Laparoscopy was used to assess ovarian activity and aspirate follicular oocytes that were graded on the basis of morphology. In five cats per treatment, half of the high-quality oocytes were assessed for glucose, pyruvate, and lactate metabolism as well as nuclear maturation. Remaining oocytes were inseminated in vitro, cultured, and examined at 72 h after insemination for cleavage. In the remaining four cats per treatment, all oocytes were inseminated in vitro and assessed at 72, 120, and 168 h after insemination for embryo developmental stage. Cats pretreated with progestin had more follicles and produced more embryos per donor (including at the combined morula/blastocyst stage) than controls or females treated with GnRH antagonist (P , 0.05). There were no differences among groups (P . 0.05) in oocyte carbohydrate metabolism, nuclear maturation metrics, or fertilization success, although there was a tendency toward improvements in all three (P , 0.2) in progestin-treated females. Interestingly, cats that spontaneously ovulated within 60 days of treatment onset also produced more embryos per cat than induced-ovulation counterparts (P , 0.05). Results indicate that prior exposure to exogenous progestin (via implant) or endogenous progestagen (via spontaneous ovulation) improves ovarian responsiveness to gonadotropins in the cat through a mechanism that is independent of the induction of ovarian quiescence.
INTRODUCTION
Exogenous progestins have been used extensively to control and synchronize ovarian cycles for assisted breeding in many domestic species and nondomestic ruminants, but little research has focused on the question of how progestin exposure improves ovarian response [1] [2] [3] [4] . Most of the literature attributes the success of these agents to ovarian suppression or synchronization alone, specifically the synchronized recruitment of a cohort of follicles that are stimulated in an early gonadotropin-responsive stage or that develop and ovulate predictably [1] . However, it is increasingly clear that progestin exposure induces complex changes in the ovary that are not attributable to ovarian quiescence alone. In ruminants, progestins advance estrus in prepubertal and anestrous individuals [2, 3] . In cattle, the addition of short-term progestin to the GnRH-based synchronization protocol called Ovsynch results in improved follicle numbers and oocyte recovery [4] . Thus, there is some indication that progestin exposure changes the fundamental function of the ovary, serving a purpose as a primer as well as ensuring ovarian suppression.
The domestic cat is an important model for understanding the influence of progestin exposure on ovarian function. In general, cats are induced ovulators, releasing an oocyte only after the appropriate copulatory stimulus [5] [6] [7] . However, some felids (including some domestic cat populations) spontaneously ovulate intermittently or consistently in the absence of mating [8] [9] [10] [11] . Thus, cats are the only known taxon where individuals within a species can differ in expressed ovulation strategyinduced versus spontaneous ovulation [12] . This offers the chance to understand the influence of progestin in an induced ovulator that normally does not produce this hormone in the absence of mating as compared to a spontaneous ovulator that produces endogenous surges in progesterone. It also presents the opportunity to compare the impact of exogenous progestin exposure on ovarian function to that of endogenous progestagen.
The domestic cat is also an important model for understanding the importance of ovarian control and suppression in improving assisted breeding success. Cat embryos are readily produced in vitro after ovarian stimulation with gonadotropins and after oocyte aspiration/insemination in vitro [13, 14] . Additionally, similar gonadotropin and in vitro fertilization (IVF) protocols have been useful in producing embryos in wild felids, including the leopard cat (Prionailurus bengalensis) [15] , tiger (Panthera tigris) [16, 17] , cheetah (Acinonyx jubatus) [18] , ocelot (Leopardus pardalis) [19] , Indian desert cat (Felis silvestris ornata) [20] , and caracal (Caracal caracal) [21] . However, there has been significant variation in ovarian response and embryo production efficiency among species and individual donors.
It is well established that developmental success in vitro for IVF cat embryos produced after exogenous gonadotropin stimulation is compromised compared to those produced after natural mating [22, 23] . At least a portion of this loss appears to be related to the exogenous gonadotropin stimulation that markedly alters the animal's internal endocrine milieu. Gonadotropin treatments are commonly associated with accessory follicle development, causing elevated and protracted estrogen secretion [24] [25] [26] as well as abnormal progesterone patterns [8, 27] . The presence of corpora hemorrhagica (CH) or fresh corpora lutea at the time of oocyte aspiration has been related to reduced IVF and embryo developmental failure. Additionally, prolonged estradiol elevations after gonadotropin stimulation are known to extend the duration of embryo transport through the cat's oviduct [28] .
The general aim of the present study was to examine the influence of progestin exposure and ovarian quiescence on controlled follicular stimulation and IVF success in the domestic cat. We especially were interested in determining if ovarian quiescence alone was sufficient to improve follicular response and oocyte quality. To distinguish the impact of progestin priming from the influence of ovarian quiescence alone, females treated with the progestin levonorgestrel were compared to those induced into a state of gonadal quiescence by down-regulation of endogenous gonadotropins via the GnRH antagonist, antide. An earlier study already had revealed an appropriate downregulation dose and delivery system for both of these agents [29] . We also sought to determine if suppressing the hypothalamo-pituitary-gonadal axis would mitigate the inconsistent ovarian responses and oocyte quality normally observed in gonadotropin-treated cats with active ovaries at treatment onset. Finally, our study took advantage of access to a colony of cats known to exhibit both induced and spontaneous ovulation. Although not a part of the original experimental design, our analysis of fecal hormone metabolites revealed that a significant proportion of cats in each treatment group had experienced at least one spontaneous ovulation in the 60 days prior to ovarian suppression treatment. Steroid hormone profiles also revealed that females exhibiting recent ovulation episodes had hormonal responses to gonadotropin stimulation that were similar to cats given the exogenous progestin treatment. Therefore, this afforded an important opportunity to assess ovarian function and IVF success in females exposed to endogenous versus no progestagen (by comparing spontaneous versus induced ovulators, respectively).
MATERIALS AND METHODS

Animals and Fecal Sample Collection
Twenty-seven adult (4-to 6-yr-old) female domestic cats from a laboratory population (Liberty Research, Inc., Waverly, NY) known to exhibit both induced and spontaneous ovulation [29] were housed at the Smithsonian's Conservation Biology Institute. Cats were maintained as singletons or same-sex pairs in cages that provided at least 0.5 m 3 of space per cat under a 12L:12D light cycle. All cats were fed a dry commercial cat diet (Purina ONE; Ralston Purina Co., St. Louis, MO) and provided water ad libitum. Project approval was secured from the Institutional Animal Care and Use Committee.
To determine if a female was prone to spontaneous ovulation, ovarian patterns for that individual were characterized by measuring steroidal metabolites in daily fecal samples from seven of nine females assigned per treatment. Two females per treatment were randomly excluded from fecal hormone analysis in trial 2 (see below). Fecal aliquots (;5 g) were collected beginning at least 60 days before GnRH antagonist or progestin administration and lasted through 60 days after hCG injection. The aliquots were frozen in vials at À208C and later assayed to identify ovulation events (see below).
Ovarian Suppression Treatments
Queens were randomly assigned to one of three treatments, with all cats in all groups treated with a single i.m. injection of equine chorionic gonadotropin (eCG; 150 IU) followed 84 h later by an i.m. injection of human chorionic gonadotropin (hCG; 100 IU; both gonadotropins from Sigma Chemical Company, St. Louis, MO). Before injecting gonadotropins, we administered one of two suppression treatments (a GnRH antagonist or progestin) that were (1) designed to provide 37 days of ovarian suppression, equivalent to the mean duration of the nonpregnancy luteal phase for the species [30] , and (2) given according to the timing and dosages determined effective in a previous study [29] . The specific treatments and cat numbers tested were 1) control, eCG, and hCG alone (n ¼ 9 cats); 2) GnRH antagonist, antide (6 mg/kg of body weight, two injections, 15 days apart; Salk Institute, La Jolla, CA), followed by eCG and hCG (n ¼ 9 cats); or 3) progestin implants (levonorgestrel [Norplant] ; six silastic rods, 36 mg levonorgestrel per rod, implanted for 37 days; Wyeth-Ayerst, Madison, NJ) followed by eCG and hCG (n ¼ 9 cats; see Gonadotropin Stimulation for more details). Hormones were administered in two trials (13 mo between trials) with 15 cats (five cats per treatment) in trial 1 and 12 cats (four per treatment) in trial 2. To account for variability across time, treatments were blocked by day, with one cat from each group receiving hormones on a given day.
The GnRH antagonist treatment with antide was administered as two s.c. injections 15 days apart starting 39 days before eCG administration. Lyophilized antagonist was stored in a sealed container at À208C, then thawed and solubilized in dimethyl sulfoxide (DMSO) before being mixed with a corn oil vehicle (final concentration 13% DMSO).
The progestin implants (six rods; 11.3 lg levonorgestrel per rod per day initial release rate) [29] were inserted beginning 39 days (Day À39) prior to eCG stimulation (Day of eCG injection ¼ Day 0) and maintained for 37 days before removal. Implant placement technique has already been described in detail [29] . In brief, each cat was induced into a surgical plane of anesthesia with 3-10 mg/kg ketamine hydrochloride (Ketaset; Aveco, Fort Dodge, IA) combined with 0.5 to 1.5 mg/kg xylazine (Xyla-ject; Phoenix Pharmaceutical Inc., St. Joseph, MO) administered i.m. and intubated, and anesthesia was maintained with isoflurane gas. With the cat in sternal recumbency, a 10-cm 2 site was surgically prepared in the dorsal cervical region cranial to the scapulae. Implant rods were placed subcutaneously in a radial pattern using a trocar inserted through a 3-cm-long incision. Implant rods were removed 37 days later (Day À2) by digital excision through a 5-cm-long incision central to the implant location in each surgically prepared, anesthetized female.
Gonadotropin Stimulation
Thirty-nine days after initiation of ovarian-suppression treatment, gonadotropin stimulation of ovarian activity for IVF was initiated. Females were treated with a single i.m. injection of 150 IU eCG (diluted in saline for injection) to induce ovarian follicular development (Day 0). Final oocyte maturation was induced with 100 IU hCG (diluted in saline for injection) given i.m. at 84 h after eCG (Day 4).
Semen Collection, Analysis, and Cryopreservation
Four proven breeder, adult cats served as sperm donors. In trial 1, fresh semen was collected on each day of scheduled follicular aspirations. In trial 2, frozen-thawed spermatozoa from one male with proven fertility were used for all IVF procedures. Semen was collected using a standardized electroejaculation procedure as previously described [31] . In brief, males were anesthetized with a combination of tiletamine hydrochloride and zolazepam hydrochloride (Telazol; ;4 mg/kg; A.H. Robins Company, Richmond, VA) administered i.m. A rectal probe (1 cm diameter) with three longitudinal electrodes was inserted, and three series of low-voltage (2-5 V) electrical stimuli (30 stimuli per series) were delivered. Semen was collected into a warmed, sterile vial and microscopically assessed for percent sperm motility and forward progressive status (scale 0 to 5: 0 ¼ no forward movement; 5 ¼ rapid, linear, forward movement) [32, 33] . Semen was diluted immediately in Ham F10 culture medium (HF10; Irvine Scientific, Santa Ana, CA) supplemented with 0.284 mg/ml glutamine, 0.026 mg/ml pyruvate, 100 IU/ ml penicillin, 100 IU/ml streptomycin, and 5% fetal calf serum (HF10 complete). Each diluted sample was centrifuged (300 3 g, 8 min), and the pellet was resuspended in HF10 complete (fresh) or TEST Yolk Buffer (frozen; Irvine Scientific, Santa Ana, CA). For fresh semen, samples with at least 50% sperm motility and 3.0 progressive status rating were swim-up processed for 30 min [13, 34] and stored for 2 h or less at 388C in 5% CO 2 in air before use for IVF. For cryopreservation, samples with at least 90% motility and 3.5 progressive status were frozen in TEST Yolk Buffer containing 4% glycerol until use [35] . Thawed aliquots with at least 75% PROGESTINS ENHANCE IVF EMBRYO DEVELOPMENT IN THE CAT 559 motility and 3.0 progressive status were washed in HF10 complete and processed as described for fresh semen. Only swim-up aliquots containing spermatozoa with a 75% motility and 3.0 progressive status rating were used for in vitro insemination.
Laparoscopic Evaluation of Ovarian Response and Oocyte Aspiration
Twenty-five to twenty-eight hours after hCG injection, females were anesthetized for a standard laparoscopic procedure to assess ovarian activity and aspirate oocytes [14, 36] . In brief, a surgical plane of anesthesia was induced and maintained as described for the progestin implant insertion procedure. For laparoscopy, females were positioned in a head-down, dorsal recumbent position, and the abdomen was insufflated with room air via a 2-mm diameter Verres needle. A trocar-cannula was inserted through the ventral midline 4 cm cranial to the umbilicus, and a 10-mm laparoscope (Olympus Corporation Inc., Melville, NY) was inserted through the cannula into the abdominal cavity. A thorough examination of the ovarian response was conducted that included assessing follicle number, size (surface diameter), and degree of vascularization (as a potential indicator of follicular maturation), as well as the numbers of fresh CH. All observations were recorded by laparoscopic photographic equipment. To better quantify ovarian response to gonadotropin stimulation, we classified a pair of ovaries on a 1 to 4 scale according to collective follicular responsiveness to exogenous gonadotropins ( Fig. 1 ), using overall follicle number, size, and prominence of apparent surface blood vessels. Specifically, a pair of grade 1 ovaries (excellent response) contained at least 14 prominent (4-5 mm in diameter), vascularized, antral follicles. A grade 2 (good) set of ovaries had fewer than 14 mature (4-5 mm in diameter) follicles. Grade 3 (moderate) ovaries had multiple follicles, but all were ,4 mm in diameter, with no evidence of surface vascularization. Grade 4 (poor) ovaries had no apparent surface follicles. The presence of CH or luteal tissue was not considered in assigning ovarian grade.
Oocytes were aspirated transabdominally under laparoscopic observation [23] into collection tubes containing HF10 complete with 40 IU/ml heparin. Quality of each oocyte was classified according to previous criteria [23, 37, 38] as grade 1 (excellent), 2 (good), 3 (moderate), or 4 (poor), with grade 1 oocytes defined by uniform, dark cytoplasm and an intact expanded cumulus investment, whereas grade 4 counterparts were devoid of cumulus and had mosaic transparency of the cytoplasm [23, 37, 38] . Treatments were blocked by surgeon as well as day of aspiration.
Oocyte Metabolism and Nuclear Maturity
Half of the grade 1 oocytes (42 total) collected from each of the 15 cats in trial 1 were assessed for carbohydrate metabolism and then nuclear maturation. The former was evaluated on the basis of techniques modified for use in our laboratory [39] [40] [41] for glucose and pyruvate uptake and lactate production over time. Oocytes were denuded of cumulus cells by gentle pipetting and washed three times in Hepes-buffered modified mouse tubal fluid [42] containing 1 mM each of glucose, pyruvate, and lactate. Each oocyte was placed individually into a microdrop of known volume (80-100 nl) of this same medium under oil on a siliconized microscope slide. Energy substrate concentration was determined using a microfluorescence assay [39] . Briefly, reagent droplets were established with a milieu of enzymes and substrates (ATP, NADP, hexokinase, and glucose-6-phosphate dehydrogenase) specifically required for oxidizing glucose and concomitantly reducing NADP þ to NADPH. Because NADPH and NADH (but not NADP þ and NAD þ ) fluoresce when excited by light of wavelength 340 nm, the amount of fluorescence produced by adding glucose to the reagent droplet reflected the amount of glucose added. Reagent droplets were assessed for initial fluorescence with an inverted fluorescent microscope (Leica Microsystems, Wetzlar, Germany) with photometer and photomultiplier attachments (Olympus). Nanoliter samples were removed from the oocyte incubation medium and added to reagent drops, which then were reassessed for fluorescence. Fluorescence generated by a given sample was used to determine glucose concentrations via a standard curve in the range of 0 to 1.0 mM for each substrate. Glucose concentration was then used to determine total glucose levels in the oocyte medium droplet. Serial nanoliter samples were removed over 3 h of culture from each oocyte microdroplet, and change in total glucose concentration over time was calculated as rate of change using linear regression. Based on similar principles, pyruvate and lactate also were measured using substrate-specific reagents. The pyruvate assay included NADH and lactate dehydrogenase, whereas the lactate assay relied on lactate dehydrogenase and NAD þ at pH levels conducive to forcing reactions to the right. Changes in glucose, pyruvate, and lactate concentration over time in a droplet containing a single oocyte were indicative of the rates of glucose and pyruvate uptake and lactate production by the oocyte. Average correlation coefficients for all standard curves for glucose, pyruvate, and lactate were 0.99, 0.99, and 1.00, respectively.
Upon completing metabolic analysis (by 6-7 h after aspiration), oocytes were assessed for nuclear maturity using the nuclear-specific stain 4 0 ,6 0 -diamidino-2-phenylindole (DAPI; Sigma) [38, 43] . Briefly, oocytes were removed from medium microdrops, placed in oocyte fixative containing 2% paraformaldehyde and 2% glutaraldehyde in 0.4 M PO 4 buffer for 30 min, and stained with 0.5 mg DAPI in the dark for 10 to 15 min. Stained oocyte groups were placed on a microscope slide with minimal medium (5 ll), and nail polish was added to form rings surrounding the oocytes. Before the polish hardened, a coverslip was placed while under observation to gently compress the oocytes without causing rupture. Each oocyte's chromatin was evaluated immediately under epifluorescence excitation at a magnification of 4003 (Diaplan microscope; Lietz, Wetzlar, Germany). Oocytes in the germinal vesicle, germinal vesicle breakdown, or metaphase I stage of development were considered immature. Oocytes in telophase of meiosis I or metaphase of meiosis II were considered mature [38, 44] .
Oocyte Fertilization, Cleavage, and Developmental Kinetics
Remaining oocytes from trial 1 not used for metabolism or maturation assessments and all oocytes recovered from the 12 cats in trial 2 were processed for in vitro insemination. For cats producing more than two oocytes, these gametes were washed three times and then placed in 40 ll HF10 complete droplets under oil (up to 10 gametes per droplet). For cats producing two or fewer oocytes, these gametes were placed together in 20-ll medium droplets. Oocytes were assigned to drops on the basis of quality, with grade 1 and grade 2 types cultured as separate groups; grade 3 and 4 counterparts were combined for culture.
Sperm concentration was determined with a hemocytometer, and oocytes were inseminated with 2 3 10 5 (fresh) or 7 3 10 5 (thawed) motile sperm per milliliter [13, 14, 35] . After 15 h of coculture, oocytes were assessed for cleavage and transferred to fresh HF10 complete medium. At least one grade 1 FIG. 1. Ovarian grade (based on follicular response) as assessed by laparoscopy at 25-28 h post-hCG injection. A) Grade 1 (excellent) response in a cat exposed to progestin-induced ovarian suppression followed by eCG/hCG. Note enlarged ovary with multiple, antral (4-5 mm diameter), wellvascularized follicles. B) Grade 2 (good) response in a cat exposed to GnRH antagonist-induced ovarian suppression followed by eCG/hCG. C, D) Grade 3 (moderate; C) and Grade 4 (poor; D) response in cats exposed to eCG/hCG stimulation alone (control). Black arrows indicate the ovary. Each white arrowhead indicates a mature, vascularized follicle.
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or 2 oocyte per cat was cultured in an identical medium droplet without sperm to assess incidence of parthenogenesis. Oocytes and parthenogenetic controls were assessed for cleavage at 72 h (Hour 0 ¼ time of insemination). Embryos at 2-cell or beyond at this time were considered fertilized, whereas 1-cell oocytes were designated as unfertilized.
All resulting embryos from trial 2 donors were transferred to a fresh HF10 drop at 72 h and again at 120 h, and each was assessed visually for stage of development at 72, 120, and 168 h after insemination. On medium transfer days, embryos of similar developmental stage and quality were combined and cultured together, and degenerating, poor-quality embryos were maintained together. At 168 h, all embryos and parthenogenetic controls were assessed for cell number by DAPI staining (see methods for evaluating nuclear maturation) [35, 38, 41] . Embryos with .16 cells were considered morula stage.
Determination of Ovulatory Type
Results of endocrine analysis from the cats in the present study were published separately [45] . These assessments of fecal progesterone metabolites allowed for the identification of ovulatory type in each cat [45] . That investigation revealed a remarkably similar endocrine profile in cats that spontaneously ovulated before inhibition treatment and those that were induced ovulators that received the levonorgestrel implants. Therefore, we included a comparison ex post facto of follicular response and oocyte quality in spontaneous versus induced ovulators in the present study. Ovulatory type determination was identical for both analyses [45] .
The radioimmunoassay sensitivity for progestagen assessment (based on 90% maximum binding) was 4 pg/ml. Intra-(based on sample values) and inter-(based on two control sample values) assay coefficients of variation remained ,10% for the assay. All fecal data were expressed on a per-gram wet weight basis. For each female, baseline progesterone metabolite levels were calculated using an iterative process in which values that exceeded the mean þ 1.5 SD were excluded. The average then was recalculated and the elimination process repeated until no values exceeded the mean þ 1.5 SD [28, 46] . The average of the remaining values then was considered baseline for that animal. Values greater than three times baseline were considered elevated. Onset of the luteal phase was defined as the first point after which values increased and remained elevated above three times baseline for at least 3 consecutive weeks. The end of the luteal phase was defined as the first of two consecutive measured values that returned to baseline concentrations. Females not exhibiting a luteal phase prior to ovarian suppression treatment were considered induced ovulators. Cats that exhibited at least one luteal phase prior to the onset of suppression treatment were classified as spontaneous ovulators.
Data Analyses
Variables not exhibiting normality or random variance (CH or oocyte number, ovarian volume, percentage blastocyst formation) were transformed before analysis using log transformations. Differences in ovarian metrics (i.e., grade, follicle, and CH number) and oocyte grade, metabolism rates, nuclear maturation, fertilization, and subsequent embryo development across treatments were assessed by a mixed-model ANOVA with a least significant difference (LSD) means comparison test (SAS 9.1 Software, SAS Institute Inc., Cary, NC) blocked by day of aspiration. Mean linear change in glucose and pyruvate uptake and lactate production over time (metabolic rate) was calculated for each oocyte, and oocyte metabolic rates were averaged for each cat. Embryo development kinetics data were analyzed using a repeated measures mixed model analysis with LSD means comparison (SAS 9.1 Software, SAS Institute Inc.). To assure that females of unknown ovulation status did not skew results of the initial treatment evaluation, analyses were repeated with the two unknown females removed.
Because no females in the control treatment group exhibited spontaneous ovulation, comparison of spontaneously ovulating versus induced-ovulation cats was made across the GnRH antagonist and progestin groups, with control females excluded from the analysis. This was valid as the primary objective of this evaluation was to determine if the results from natural progesterone exposure in the spontaneously ovulating/GnRH antagonist-treated cats mimicked that of cats receiving the progestin implants. Effect of ovulatory type and interactions between ovulatory type and treatment were compared using a mixed model ANOVA with an LSD means comparison test. Variables not exhibiting normality or random variance (follicle number, ovarian grade, proportion of grade 1 oocytes and proportion of grade 1 and 2 oocytes) were transformed prior to analysis using log transformations. Correlation coefficients were determined using Spearman rank correlation analysis (SAS 9.1 Software, SAS Institute Inc.).
RESULTS
Ovarian Response, Oocyte Recovery, and Fertilization
For overall gonadal quality, ovarian grade was superior (P , 0.05) in progestin compared to GnRH antagonist-treated cats, with the latter improved (P , 0.05) over controls ( Of the 27 females subjected to laparoscopy, 15 (56%) had at least one ovary with fresh luteal tissue (range, 1-7 CH per cat), indicating pre-aspiration ovulation. The incidence of these preaspiration ovulation events (i.e., spontaneous ovulation) occurred with similar (P . 0.05) frequency and number among groups (Table 1) .
Ovarian suppression with progestin followed by gonadotropin stimulation was associated with more (P , 0.05) follicles per cat compared to control (more than double) or GnRH antagonist-treated females (Table 1) . Although not statistically different (P . 0.05), progestin-treated queens averaged greater than three more oocytes compared to control and GnRH antagonist-treated counterparts (Table 1) . Likewise, progestin pretreatment resulted in at least four more grade 1 (P ¼ 0.16) or grade 1 and 2 (P ¼ 0.18) oocytes per cat and a higher (P , 0.05) overall proportion of grade 1 and 2 oocytes than controls ( Table 1) .
Incidence of parthenogenesis in vitro (3.3%) was similar to previous studies [13, 47] , and the two resulting cleaved oocytes failed to develop beyond 2-cells. In inseminated oocytes, fertilization success was related to oocyte quality; that is, incidence of cleavage tended to be higher (P ¼ 0.15) in progestin pretreated queens and was .25% higher than controls (Table 1) . Progestin treatment also resulted in more than twice (P , 0.05) as many total embryos per cat compared to control and GnRH antagonist-treated females (Table 1) .
Down-regulation with progestin also influenced subsequent embryo developmental kinetics (Table 2) . Progestin pretreatment resulted in a trend towards a lower incidence of developmental arrest (fewer 1-cell embryos; P ¼ 0.19) and nearly twice the proportion of morulae and blastocysts. Thus, the number of embryos that reached the morula and blastocyst stage was greater (P , 0.05) in progestin-treated females (more than three times higher than controls and more than twice that of GnRH antagonist-treated females; Table 2 ). The number of blastomeres per blastocyst was nearly (P ¼ 0.14) two-fold higher in the progestin compared to counterpart groups (Table  2) .
In terms of developmental kinetics, more (P , 0.05) cleaving oocytes (.80%) reached the morula stage by 72 h after IVF following progestin-exposure compared to controls (;30%; Fig. 2 ). The rate for GnRH antagonist-treated females (;50%) was intermediate (P . 0.05) between the other treatments (Fig. 2) . There was gradual blastocyst development over the culture interval in all three groups, although at a significant level (P , 0.05) only in cats serving as controls or treated with progestin.
When data were reevaluated with the two females of unknown ovulation status removed, results were similar to those presented with all females included (data not shown).
Metabolism and Nuclear Maturation
Cytoplasmic maturation (assessed by glucose and pyruvate uptake and lactate production from denuded oocytes) did not differ (P . 0.05) among treatments (Table 3) . Additionally, oocytes from all treatments achieved a high rate (.85%) of nuclear maturation as assessed by DAPI staining (Table 3) .
Oocyte and Embryogenic Response in Induced Versus Spontaneous Ovulators
Of the seven females receiving progestin exposure and the seven injected with GnRH antagonist, four in each treatment showed clear evidence of spontaneous ovulation. Representative endocrine profiles for females of both ovulatory types from each treatment group are depicted in Figure 3 . There was no 562 interaction (P . 0.05) between the two ovulation types and response to either ovarian suppression treatment. There were four spontaneously ovulating cats in each of the two treatment groups, and none in the control cohort. Cats spontaneously ovulating prior to onset of suppression treatment (n ¼ 8 of 14 queens) with progestin or GnRH antagonist produced, on average, more than four additional follicles and five more grade 1 and 2 oocytes compared to induced ovulating counterparts (Table 4) . Although these specific metrics were not significant (P . 0.05), the proportion of grade 1 oocytes was more than double (P , 0.05), and the combined percentage of grade 1 and 2 oocytes was .20% higher (P , 0.05) in spontaneous compared to induced-ovulation cats ( Table 4) . As a result, the incidence of fertilization success and the number of embryos per cat both increased by more than two-fold (P , 0.05) in the former compared to the latter (Table 4 ).
DISCUSSION
Our overall aim was to understand the impact of progestin exposure and gonadal suppression on subsequent ovarian response to gonadotropin stimulation and on oocyte and embryo quality in the cat. Our experimental design comparing ovarian suppression with the progestin levonorgestrel to pituitary-based down-regulation of the ovary using the GnRH antagonist, antide, allowed generating new insights into progestin control of ovarian function and reactivity to exogenous gonadotropins. Specifically, ovarian follicular response (including overall ovarian grade) and proportions of high-quality oocytes and rapidly developing embryos were enhanced by both ovarian suppression treatments (progestin or GnRH antagonist) compared to freely cycling females. However, pretreatment with progestin (in this case administered via implant) was, in turn, superior to the GnRH antagonist. Progestin pretreatment produced more follicles, more high-quality oocytes, and eventually more rapidly developing embryos in vitro, at least to the morula stage, than females receiving GnRH antagonist. This indicated that ovarian quiescence alone was insufficient to explain the beneficial effects of progestin exposure. Interestingly, cats that ovulated spontaneously prior to treatment experienced a similar heightened ovarian response to females given exogenous progestin pretreatment, indicating that endogenous progestagen exposure (whatever the source) had a similar priming influence that was independent of ovarian quiescence at the time of gonadotropin stimulation. This effect appeared to be largely expressed by allowing more efficient production of good-toexcellent quality oocytes from more viable follicles. Although there was no difference among treatments in oocyte metabolic ability, capacity to achieve metaphase II in vitro (both indicators of cytoplasmic and nuclear competency, respectively), or fertilization success, there was a strong tendency for all of these factors to be improved, indicating a possible direct impact on oocyte quality. Thus, early progestin exposure is likely to induce gonadal changes that sensitize the ovary to be highly responsive to an FSH-and LH-like stimulus that subsequently improves follicular response and IVF success. Ovarian suppression prior to gonadotropin stimulation improves ovarian response to gonadotropin stimulation in the cow [48] , sheep [49] , various nondomestic ruminants [50] , cetaceans [51] , and humans [52] . The most common postulated reason is that a down-regulated ovary is more sensitized and likely to produce a uniform follicular response to gonadotropin(s) in the gonadotropin-sensitive early antral phase of development. Therefore, a hormonal stimulus (either endogenous or exogenous) is better able to recruit a cohort of follicles of similar stage, thereby enhancing synchronized antral growth and ovulation of best quality oocytes [1, 53] . Data from our study confirmed that a similar effect occurs in domestic cats that are down-regulated using progestin or a GnRH antagonist.
Results from treating cats with GnRH antagonist revealed that gonadal quiescence alone was inadequate to explain the benefits of progestin pretreatment. Females down-regulated with this pituitary-specific agent maintained several improvements over controls alone, for example, in ovarian grade and proportion of high-grade oocytes recovered. This observation was consistent with findings observed in humans treated with GnRH antagonists where it has been possible to improve oocyte recovery and pregnancy success after gonadotropin stimulation [54] . By comparison though, ovarian quiescence achieved in the cat by progestin implant was superior for enhancing overall follicular response, proportion of highquality oocytes recovered, number of oocytes cleaving, advanced embryos produced, and the rate of embryo development. It also was interesting that GnRH antagonist pretreatment in the cat, though successful in inducing ovarian quiescence at the time of gonadotropin treatment [45] , appeared to be associated with an enhanced morula-toblastocyst developmental block (compared to control or progestin-treated counterparts; Fig. 3 ). Therefore, in this species, reducing ovarian activity by eliciting a hypogonadotropic environment may be detrimental to oocyte function. Clearly, ovarian quiescence alone is not a sufficient requirement for improving ovarian response to gonadotropin treatment in the cat.
Progestin treatment, in contrast, resulted in marked improvements in ovarian response to gonadotropins beyond those seen in GnRH antagonist down-regulated females. Females pre-treated with progestins had more follicles on their ovaries, a higher proportion of excellent quality eggs, and ultimately more embryos produced. A progestagen-specific ovarian priming function in cats is further suggested by similar results in spontaneously ovulating females experiencing elevations in endogenous progestagens versus exclusively induced ovulators that did not have such elevations (Table  4) . This priming advantage has been observed in other species, including for advancing estrus in acyclic or prepubertal individuals, probably by heightening ovarian reactivity to pituitary stimulation [2, 3] . Indeed, progestagen exposure has improved numbers of ovulations and embryo survival in naturally mated, early weaned sows [2] and eliminated ovarian cysts in cows, resetting the reproductive axis to normal ovarian cyclicity [55, 56] . These direct effects of progesterone on the ovary are not well understood in any species. Progestagens are known to alter both receptor populations and hormone production and release at all levels of the reproductive axis in other species [57] [58] [59] . Progesterone suppresses growth of developing ovarian follicles in rabbits, rodents, and nonhuman primates [60] , in part by directly suppressing granulosa cell mitosis and proliferation [61, 62] . Progesterone pretreatment of anestrous ewes before GnRH stimulation prevents luteal insufficiency [63, 64] , whereas isolated, cultured follicles from progestagen-treated ewes produce more estradiol in response to LH than counterparts unexposed to progesterone [63, 64] .
That progesterone exposure may also have a direct influence on oocyte quality, as indicated in this study by the trend toward improved glucose metabolism, nuclear maturation, and embry- onic development in progestagen-treated cats, is not a novel assertion. Oocytes recovered from mice pretreated with levonorgestrel before exogenous gonadotropins are more successful at fertilization and development in vitro than untreated counterparts [65] . Inherent variability in this dataset, likely due to a mixed population of induced and spontaneously ovulating cats, may have prohibited a robust comparison of oocyte quality in the present study, resulting in trends and no significant results. Future research will need to control for ovulation mechanisms to ensure a more accurate comparison of ovarian function associated with exogenous treatments.
We suspect that progestin priming in the cat is exerting a benefit primarily at the level of the ovarian follicle. This may be allowing gonadotropin exposure to be more effective in recruiting into the antral growth phase (resulting in more follicles) and then promoting more efficient growth of early antral follicles that contain high-quality oocytes (resulting in higher quality oocytes). It could be that progestagen exposure slows antral follicle atresia, resulting in a larger overall population of early antral gonadotropin-receptive follicles at the time of gonadotropin exposure. Such a mechanism, however, fails to account for all of the effects we observed, and similar positive follicular responses were observed in females exposed to endogenous progesterone days to weeks prior to gonadotropin stimulation. Therefore, there seemed to be a protracted influence of progesterone priming, perhaps similar to enhancements in follicular gonadotropin receptor populations as measured in similarly treated anestrous ewes [60] . Membrane-based progesterone receptors are detectable in granulosa cells just prior to ovulation in nonhuman primates, although the activation and purpose of these receptors are poorly understood [60] . If such a mechanism exists in the domestic cat, then it appears that activation of these granulosa cell receptors results in alteration of gonadotropin receptor populations either in number or in sensitivity over protracted time periods to increase ovarian response to exogenous gonadotropin stimulation.
Metabolism results supported earlier studies indicating that glucose metabolism can predict embryo development to morula and blastocyst stages in vitro [35] . Spindler et al. [35] determined that oocytes with high rates of glucose metabolism were more likely to develop to advanced stages of embryonic development. In the present study, all treatments produced oocytes with carbohydrate metabolism and nuclear maturation rates similar to those seen previously in high-quality oocytes from cats [38, 40, 41, 66] . Consistent with these high metabolism rates in aspirated oocytes, there also was no difference in oocyte fertilization rates or the proportion of oocytes reaching advanced stages of embryonic development following IVF. In cats, therefore, as in the mouse [67] , human [68] , and pig [69] , oocyte glycolysis appears to be a consistent quantitative marker of oocyte developmental capacity.
The dramatic improvements observed in ovarian, oocyte, and embryo traits in females that exhibited ovulation in the 60 days prior to ovarian inhibition treatment (compared to females that did not ovulate prior to inhibition treatment) indicated an influence of endogenous progesterone that mimicked the exogenous levonorgestrel treatments. This may provide interesting insight into the control mechanisms of felid ovulation. Although felids have long been classified as induced ovulators that release ova exclusively in response to copulation, a series of studies have determined that many individual animals in felid populations are prone to spontaneous ovulation. Felid species found to exhibit this individual variation in ovulation control include the lion (Panthera leo) [70] , clouded leopard (Neofelis nebulosa) [8] , margay (Leopardus weidii) [11] , and domestic cat [9, 29, 71] . In the latter species, these ovulation events are not associated with any known olfactory or physical stimulation events [9, 29, 71] and are equally prevalent in females housed as pairs versus singletons [9, 29, 71] . One study from our laboratory compared endocrine response to gonadotropin stimulation in domestic cats and determined that those animals exhibiting spontaneous ovulation had longer estrogen surges compared to females that did not ovulate [71] . The differences in follicular response to gonadotropin stimulation and oocyte and endocrine function between induced versus spontaneous ovulators point to a distinctive difference in ovarian physiology. Based on findings in the present study, the priming function of progesterone likely helps establish if a given cat eventually may spontaneously ovulate. We postulate that ovulation and elevated endogenous progesterone likely sensitize the ovary to ensuing endogenous gonadotropin surges, resulting in an increased susceptibility to spontaneous ovulation in subsequent estrous cycles. Therefore, the occasional spontaneous ovulation events observed in domestic cats may be based on physiological rather than environmental factors, making the cat an intriguing research subject for understanding mechanisms of ovulation, particularly in relation to progesterone function and priming.
The existence of two distinct ovulatory mechanisms in the domestic cat (and other felid species) likely play a role in the significant variations observed in ovarian responses to a standardized gonadotropin protocol. We found it intriguing that spontaneous ovulators were better performers in our IVF assessments, most likely due to a priming effect of progesterone that occurred sometime during the 60-day interval before gonadotropin treatment. In the current study, none of the seven females in the control treatment assessed by fecal hormone analysis ovulated in the 60 days prior to treatment. This alone might account for the improvement in IVF results in progestintreated versus control females based on the apparent priming effect of endogenous progesterone. Indeed, this inherent variability in response between induced and spontaneous ovulators might account for the lack of significance in difference between treatments in oocyte quality measures, including glucose metabolism, nuclear maturity, fertilization rates, and embryo development. Ascertaining the true impact of priming progesterone on oocyte quality would require future experiments that compare similar populations of spontaneous versus induced ovulating cats, especially with the former as controls.
In conclusion, our findings indicated that progesterone played an intriguing and important role in priming the cat ovary to better respond to gonadotropin stimulation, resulting in more follicles with higher quality oocytes that were better able to fertilize and develop rapidly to advanced embryo stages in vitro. The effect clearly was expressed independent of simply inducing ovarian quiescence, because enhanced responsiveness also was observed in females producing endogenous progestagen from spontaneous ovulations, sometimes as early as 90 days prior to stimulation, which was not observed in ovaries down-regulated through pituitary pathways. A likely target requiring more examination is progesterone's impact on gonadotropin receptor populations and activity in the ovary. The ability of the cat to ovulate both spontaneously as well as after copulation-induced ovulation offers a unique model for more clearly understanding the role of progesterone priming on ovarian function, especially follicular recruitment, oocyte quality, fertilization, and early embryo development.
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